Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (4 quarters reported)
$22.1M in Q4 2014 → $13.6M now. Hover for any quarter.
As reported for the quarter ended September 30, 2015. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| AP Acceleron Pharma Inc. | 97.4% | Unchanged | 530,919 | $13.2M |
| BM Bg Medicine, Inc. | 2.6% | Trimmed 72% | 863,269 | $354K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.
quarter ended September 30, 2015 · filed November 13, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BM Bg Medicine, Inc. | Trimmed | −2,203,192 | −$903K | 2.6% |
quarter ended June 30, 2015 · filed July 28, 2015
No position changes this quarter.
quarter ended March 31, 2015 · filed April 30, 2015
No position changes this quarter.
Loading...
